Literature DB >> 14500006

Detection of Mycoplasma pneumoniae in respiratory samples by real-time PCR using an inhibition control.

Dominique Ursi1, Kristien Dirven, Katherine Loens, Margareta Ieven, Herman Goossens.   

Abstract

Polymerase chain reaction (PCR) with real-time detection using two adjacent fluorescent probes in a Lightcycler instrument was applied for detection of the Mycoplasma pneumoniae P1 protein gene. To monitor inhibition in each sample an internal control was constructed that can be amplified by the same primers but detected by different probes and dual color detection. The real-time PCR was applied on 115 respiratory samples from 82 patients and compared to a conventional PCR. There was 100% agreement between the assays, but the real-time PCR proved to be highly superior in speed with a much lower risk of false positives by laboratory contamination.

Entities:  

Mesh:

Year:  2003        PMID: 14500006     DOI: 10.1016/s0167-7012(03)00131-3

Source DB:  PubMed          Journal:  J Microbiol Methods        ISSN: 0167-7012            Impact factor:   2.363


  25 in total

1.  Fatal outcomes in family transmission of Mycoplasma pneumoniae.

Authors:  T R Kannan; R D Hardy; J J Coalson; D C Cavuoti; J D Siegel; M Cagle; O Musatovova; C Herrera; J B Baseman
Journal:  Clin Infect Dis       Date:  2011-11-03       Impact factor: 9.079

2.  Evaluation of 12 commercial tests and the complement fixation test for Mycoplasma pneumoniae-specific immunoglobulin G (IgG) and IgM antibodies, with PCR used as the "gold standard".

Authors:  Matthias F C Beersma; Kristien Dirven; Alje P van Dam; Kate E Templeton; Eric C J Claas; Herman Goossens
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

3.  Evaluation of NucliSens easyMAG for automated nucleic acid extraction from various clinical specimens.

Authors:  K Loens; K Bergs; D Ursi; H Goossens; M Ieven
Journal:  J Clin Microbiol       Date:  2006-12-13       Impact factor: 5.948

Review 4.  Real-time PCR in clinical microbiology: applications for routine laboratory testing.

Authors:  M J Espy; J R Uhl; L M Sloan; S P Buckwalter; M F Jones; E A Vetter; J D C Yao; N L Wengenack; J E Rosenblatt; F R Cockerill; T F Smith
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

5.  Simultaneous detection of Chlamydophila pneumoniae and Mycoplasma pneumoniae by use of molecular beacons in a duplex real-time PCR.

Authors:  Karolina Gullsby; Martin Storm; Kåre Bondeson
Journal:  J Clin Microbiol       Date:  2007-12-19       Impact factor: 5.948

6.  Sensitive detection of Mycoplasma pneumoniae in human respiratory tract samples by optimized real-time PCR approach.

Authors:  Roger Dumke; Nicol Schurwanz; Matthias Lenz; Markus Schuppler; Christian Lück; Enno Jacobs
Journal:  J Clin Microbiol       Date:  2007-05-30       Impact factor: 5.948

7.  Two quality control exercises involving nucleic acid amplification methods for detection of Mycoplasma pneumoniae and Chlamydophila pneumoniae and carried out 2 years apart (in 2002 and 2004).

Authors:  K Loens; T Beck; D Ursi; S Pattyn; H Goossens; M Ieven
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

8.  Comparison of commercial and in-house real-time PCR assays used for detection of Mycoplasma pneumoniae.

Authors:  Roger Dumke; Enno Jacobs
Journal:  J Clin Microbiol       Date:  2008-12-10       Impact factor: 5.948

9.  Evaluation of five commercial real-time PCR assays for detection of Mycoplasma pneumoniae in respiratory tract specimens.

Authors:  A Touati; A Benard; A Ben Hassen; C M Bébéar; S Pereyre
Journal:  J Clin Microbiol       Date:  2009-04-29       Impact factor: 5.948

10.  Mycoplasma pneumoniae Community Acquired Respiratory Distress Syndrome toxin expression reveals growth phase and infection-dependent regulation.

Authors:  T R Kannan; Oxana Musatovova; Sowmya Balasubramanian; Marianna Cagle; Jarrat L Jordan; Thomas M Krunkosky; Alan Davis; Robert D Hardy; Joel B Baseman
Journal:  Mol Microbiol       Date:  2010-02-28       Impact factor: 3.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.